Dimitri Daldegan-Bueno (D Daldegan-Bueno)

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 14

Top Venues

Journal of psychoactive drugs

Trials

Substance abuse treatment, prevention, and policy

Psychopharmacology

The University of Auckland

This page only lists publications with an associated author ORCID identifier.

Affiliation History

The University of Auckland Jan 26 2020

New Zealand

Research Assistant :: Faculty of Medical and Health Sciences

Publications

Dimitri Daldegan-Bueno, Carina Joy Donegan, Anna Forsyth, Rachael Louise Sumner, Robin J Murphy, David B Menkes, William Evans, Nicholas R Hoeh, Frederick Sundram, Lisa M Reynolds, Rhys Ponton, Alana Cavadino, Todd Smith, Partha Roop, Nathan Allen, Binu Abeysinghe, Darren Svirskis, Mahima Bansal, Suresh Muthukumaraswamy
LSDDEP2: study protocol for a randomised, double-dummy, triple-blind, active placebo-controlled, parallel groups trial of LSD microdosing in patients with major depressive disorder. Trials 25 (1) (2024)
Dimitri Daldegan-Bueno, Carina Joy Donegan, Anna Forsyth, Rachael Louise Sumner, Robin J Murphy, David B Menkes, William Evans, Nicholas R Hoeh, Frederick Sundram, Lisa M Reynolds, Rhys Ponton, Alana Cavadino, Todd Smith, Partha Roop, Nathan Allen, Binu Abeysinghe, Darren Svirskis, Mahima Bansal, Suresh Muthukumaraswamy
LSDDEP2: study protocol for a randomised, double-dummy, triple-blind, active placebo-controlled, parallel groups trial of LSD microdosing in patients with major depressive disorder. Trials 25 (1) (2024)
Dimitri Daldegan-Bueno, Carina Joy Donegan, Anna Forsyth, Rachael Louise Sumner, Robin J Murphy, David B Menkes, William Evans, Nicholas R Hoeh, Frederick Sundram, Lisa M Reynolds, Rhys Ponton, Alana Cavadino, Todd Smith, Partha Roop, Nathan Allen, Binu Abeysinghe, Darren Svirskis, Mahima Bansal, Suresh Muthukumaraswamy
LSDDEP2: study protocol for a randomised, double-dummy, triple-blind, active placebo-controlled, parallel groups trial of LSD microdosing in patients with major depressive disorder. Trials 25 (1) (2024)
Alexandre Augusto de Deus Pontual, H G Senhorini, C M Corradi-Webster, Luís Fernando Farah de Tófoli, Dimitri Daldegan-Bueno
Systematic Review of Psychometric Instruments Used in Research with Psychedelics. Journal of psychoactive drugs (2022)
Isabel Wießner, Marcelo Falchi, Lucas Oliveira Maia, Dimitri Daldegan-Bueno, Fernanda Palhano-Fontes, Natasha L Mason, Johannes G Ramaekers, Madeleine E Gross, Jonathan W Schooler, Amanda Feilding, Sidarta Ribeiro, Draulio B de Araujo, Luís Fernando Tófoli
LSD and creativity: Increased novelty and symbolic thinking, decreased utility and convergent thinking. Journal of psychopharmacology (Oxford, England) 36 (3) (2022)
Dimitri Daldegan-Bueno, Sheila Rubia Lindner, Douglas Francisco Kovaleski, Benedikt Fischer
Cannabis use, risk behaviours and harms in Brazil: A comprehensive review of available data indicators. Drug and alcohol review (2022)
Dimitri Daldegan-Bueno, Dóra Révész, Paulo Rogério Morais, Paulo Cesar Ribeiro Barbosa, Lucas Oliveira Maia
Psychosocial and Drug Use Assessment of Regular vs. Non-Regular Ayahuasca Users in a Brazilian Sample: a Web-Based Survey. Substance use & misuse 57 (7) (2022)
Dimitri Daldegan-Bueno, Lucas Oliveira Maia, Carolina Marcolino Massarentti, Luís Fernando Farah de Tófoli
Ayahuasca and tobacco smoking cessation: results from an online survey in Brazil. Psychopharmacology 239 (6) (2022)
Dimitri Daldegan-Bueno, Sheila Rubia Lindner, Benedikt Fischer
Conceptualizing and considering Cannabis-Related "Harm-to-Others": The Role of Cannabis-Related Violence. Substance use & misuse 57 (9) (2022)
Benedikt Fischer, Caroline O'Keefe-Markman, Angelica Min-Hye Lee, Dimitri Daldegan-Bueno
'Resurgent', 'twin' or 'silent' epidemic? A select data overview and observations on increasing psycho-stimulant use and harms in North America. Substance abuse treatment, prevention, and policy 16 (1) (2021)
Dimitri Daldegan-Bueno, Vanessa Manchim Favaro, Luís Fernando Farah de Tófoli, Alessandra Sussulini, Fernando Cassas, Maria Gabriela Menezes Oliveira
Ayahuasca Lyophilization (Freeze-drying) Protocol with Pre- and Post-procedure Alkaloids Quantification. Journal of psychoactive drugs (2021)
Lucas Oliveira Maia, Dimitri Daldegan-Bueno, Benedikt Fischer
Opioid use, regulation, and harms in Brazil: a comprehensive narrative overview of available data and indicators. Substance abuse treatment, prevention, and policy 16 (1) (2021)
Dimitri Daldegan-Bueno, Lucas Oliveira Maia, Michelle Glass, Didier Jutras-Aswad, Benedikt Fischer
Co-exposure of cannabinoids with amphetamines and biological, behavioural and health outcomes: a scoping review of animal and human studies. Psychopharmacology (2021)
Lucas Oliveira Maia, Dimitri Daldegan-Bueno, Luís Fernando Farah de Tófoli
The ritual use of ayahuasca during treatment of severe physical illnesses: a qualitative study. Journal of psychoactive drugs 53 (3) (2020)

Dimitri Daldegan-Bueno.css-eqlu8i{font-size:small;padding-left:4px;} (D Daldegan-Bueno)

Publication Activity (10 Years)

Top Topics

Top Venues

Dimitri Daldegan-Bueno (D Daldegan-Bueno)